Progress in the discovery and development of glutamate carboxypeptidase II inhibitors.

Drug Discov Today

MGI Pharma, Inc., 6611 Tributary Street, Baltimore, MD 21224, USA.

Published: September 2007

During the past 10 years, substantial progress has been made in the discovery and development of small molecule glutamate carboxypeptidase II (GCP II) inhibitors. These inhibitors have provided the necessary tools to investigate the physiological role of GCP II as well as the potential therapeutic benefits of its inhibition in neurological disorders of glutamatergic dysregulation. This review article details key GCP II inhibitors discovered in the last decade and important findings from preclinical and clinical studies.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.drudis.2007.07.010DOI Listing

Publication Analysis

Top Keywords

progress discovery
8
discovery development
8
glutamate carboxypeptidase
8
gcp inhibitors
8
development glutamate
4
inhibitors
4
carboxypeptidase inhibitors
4
inhibitors years
4
years substantial
4
substantial progress
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!